Company page

Celltrion, Inc.

Celltrion, Inc. is a public company listed on the Korea Stock Exchange under the ticker 068270. With a market capitalization of approximately 23.6 trillion KRW, the company is involved in the biopharmaceutical industry, focusing on the development and manufacturing of innovative therapies. Celltrion aims to enhance healthcare solutions through its advanced biologics and biosimilars.